To include your compound in the COVID-19 Resource Center, submit it here.

Generic enoxaparin regulatory update

Aventis S.A. (AVE, Strasbourg, France) said the FDA

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE